Streetwise Reports' Article Archives — September 2022 back to current month (93)
Interim Results From Phase 2b Trial Are 'Encouraging' (09/30/2022)
Data show the biotech's compound had a positive effect on several noninvasive measures, noted a ROTH Capital Partners report.
Miner Finds Vast Nickel System in Brazil (09/30/2022)
Ero Copper Corp. shares traded more than 7% higher on a down market yesterday after the company reported it discovered a new nickel sulfide system within Brazil's Curaçá Valley. In an area historically known for rich copper deposits, the firm reported that drill results from the system's VB zone returned 16.5m of 1.22% nickel which included 3.8m of 3.60% nickel.
Clean Tech Co. Might Be 'Intrinsically Strong' (09/30/2022)
Expert Clive Maund reviews Ecolomondo Corp.'s 6-month and 2-year charts to show you why he believes this stock may be strong no matter the market.
Biopharma Co. Awarded FDA Clearance for Advanced Solid Tumors Trial (09/30/2022)
Shares of oncology-focused biopharmaceutical company Immuneering Corp. traded 9% higher after the firm reported it received U.S. FDA clearance for its IND Application for a Phase 1/2a clinical trial of IMM-1-104 for use in treatment of advanced solid tumors with RAS mutations. The company expects to enroll the first patient in the study in Q4/22.
Pharma Co. Meets Primary Endpoint in Phase 3 Alzheimer's Trial (09/29/2022)
Shares of Eisai Co. Ltd. traded 58% higher yesterday after the company reported topline data from its global Phase 3 clinical study demonstrating that its lecanemab significantly met the primary and key secondary endpoints in reducing mild cognitive impairment due to Alzheimer's disease.
Silver Explorer 'Could Be Sitting on Three-Four Million Ounces' (09/29/2022)
After speaking with the president and CEO of Arizona Silver Exploration Inc., editor and publisher of The National Investor, Chris Temple, shares why he believes its Philadelphia Project is compelling.
Expert Says Lithium Co. 'An Immediate Speculative Buy' (09/29/2022)
Expert Clive Maund takes a look at the 6-month and 2-year charts for Spey Resources Corp., following the completion of a large base pattern, to tell you whether he believes it is a Buy.
Biopharma Asks for Emergent Use in US of New COVID Drug (09/29/2022)
The requested approval is specifically for critically ill patients, a population for which the U.S. Food and Drug Administration granted the therapeutic fast track status, noted an H.C. Wainwright & Co. report.
Co. Builds Copper Gold Resource at Asset Near Large Miner (09/28/2022)
This mining firm with a robust project portfolio is exploring its newly acquired asset in Chile's Atacama region, from which results are expected soon, noted a Fundamental Research Corp. report.
Counter Drone Tech Firm Differs From Rest of Market (09/27/2022)
This company warrants a favorable investment thesis and Buy recommendation based on many factors, noted a Bell Potter report.
Oncology Co.'s Shares Erupt on Signing Global License Deal (09/27/2022)
Shares of clinical-stage immuno-oncology company LAVA Therapeutics NV traded nearly 100% higher yesterday after the firm reported that it has entered into a global licensing agreement with Seagen Inc. to advance its LAVA-1223, a preclinical gamma delta bispecific T cell engager designed for use in the treatment of EGFR-expressing solid tumors.
Opportunity for Investors Found in Psychedelics Space (09/27/2022)
Treatment of alcohol use disorder with psychedelics plus therapy is effective, according to existing data, and the potential global market is large, noted an H.C. Wainwright & Co. report.
Solar Co. Amps Up Power Generating Assets (09/27/2022)
Altus Power Inc. shares traded 17% higher to a new 52-week high after the industrial, public and community solar firm reported it entered into definitive agreements to acquire 97 megawatts of operating solar assets.
The Perfect Storm for Oil and Natural Gas (09/27/2022)
Numerous positive influences on oil and gas prices are looking to converge this winter in North America and Europe. Expert Ron Struthers believes oil and gas stocks have been oversold and offer very good value, and he highlights two he thinks are worth your attention.
US Biotech Firm Keeps Growing Revenue (09/26/2022)
Revenue last quarter was strong, and management expects to increase revenue 20% this fiscal year, noted a ROTH Capital Partners report.
Junior Sells Lithium Projects to Focus on James Bay Gold (09/26/2022)
Quebec Precious Metals Corp. is selling all of its non-core assets so it can focus on its flagship Sakami gold project in the James Bay territory of Quebec.
Lithium Explorer Partners With Leading Battery Maker (09/26/2022)
Snow Lake Resources Ltd.'s shares traded 38% higher Friday after the company reported it signed an MOU with global lithium-ion battery manufacturer LG Energy Solution. Under the terms of the proposed agreement, the firms will collaborate to develop and build a lithium hydroxide processing plant in Winnipeg, Man. capable of supplying LG Energy with lithium over a 10-year period beginning in 2025.
New Assays Highlight High Copper Potential (09/26/2022)
Norseman Silver has just announced more high-grade assays of rock chip samples at its project in Argentina.
Sampling at Argentina Project Reveals Elevated Copper/Gold Values (09/26/2022)
Michael Ballanger explains why he believes sample assays provide evidence "indicating the potential for world-class scale and value."
Six Charts You Need To See Showing the Coming Bear Market (09/26/2022)
Expert Michael Ballanger takes a look at a few charts to tell you how he believes the US dollar is doing and where he thinks the market may be heading.
Green Tech Co. Uplisted to OTCQB Venture Market (09/26/2022)
Bioleaching company BacTech Environmental Corp. has begun trading on the OTCQB Venture Market as it gets ready to open a plant in Ecuador and has opened a pilot facility in Ontario.
Co.'s Clinical Program in HPV+ Cancers Gives It a Buy Rating (09/23/2022)
To fund continued development of its lead immunotherapy candidate, the U.S.-based biopharma recently completed a $35 million debt financing agreement, noted an H.C. Wainwright & Co. report.
Analyst Says Buy Before Biotech Co.'s Clinical Trials (09/23/2022)
Argenx SE has "several upcoming catalysts," noted a Wedbush report.
Cobalt Refiner Signs 3-Yr. Supply Deal With EV Battery Maker (09/23/2022)
Shares of Electra Battery Materials Corp. traded 13% higher yesterday after the company reported it entered into a 3-year supply agreement with LG Energy Solution of South Korea to provide 7,000 tonnes of cobalt sulfate for use in manufacturing batteries for electric vehicles in North America.
Gold Co. 'Looking Like a Good Value' (09/23/2022)
With good news shown on Tuesday, Strikepoint Gold Inc. has piqued expert Clive Maund's interest. Today he reviews the gold company's 3-year and 6-month charts to tell you where he believes the stock is headed.
Junior Sells Yukon Projects To Focus on Golden Triangle (09/22/2022)
StrikePoint Gold Inc. is selling its Yukon Territory properties so it can better focus on its flagship Porter and Willoughby projects in the Golden Triangle.
Timing the US Market Crash: A Roadmap (09/22/2022)
Expert Clive Maund reviews the charts for the broad stock market to tell you when he believes the U.S. market will crash.
Telemedicine Co. Says It's Set To Thrive in Post-Pandemic World (09/21/2022)
The pandemic changed the way many people get their basic healthcare, giving a big opening to telemedicine companies like Reliq Health Technologies Inc.
Expert Says Silver Co. Is a Buy up to CA$0.20 (09/21/2022)
Expert Michael Ballanger reflects on his views of Norseman Silver last April to compare his opinion of the company then versus what he sees now.
FDA Approves Hearing Loss Drug for Child Chemo Patients (09/21/2022)
Shares of Fennec Pharmaceuticals Inc. traded 14% higher after the company reported it received approval from the U.S. FDA for its PEDMARK® (sodium thiosulfate injection) for use in reducing the risk of ototoxicity in pediatric patients who are undergoing or completed chemotherapy for non-metastatic solid tumors.
Dermatology Co.'s Target Price Much Higher Than Current (09/20/2022)
The biopharma's strategic marketing campaign "should continue growing U.S. sales to current and new customers," noted a ROTH Capital Partners report.
Important Catalyst Expected Soon for Cancer Drug Co. (09/20/2022)
The biopharma should announce initial clinical trial data on its lead small molecule candidate by year-end, noted a Wedbush report.
Junior Continues Pivot With Nevada Lithium Project (09/20/2022)
Rover Metals Inc. is moving quickly as it eyes the all-important critical metals and minerals sector with a district-scale claystone lithium project in Nevada.
Biopharma Co.'s Shares Rise on Phase 3 Migraine Trial Data (09/20/2022)
Satsuma Pharmaceuticals Inc. shares traded 12% higher to a new 52-week high after the company reported positive results from its Phase 3 long-term study of STS101 for use in acute treatment of migraine attacks. The company expects to receive further efficacy data from its Phase 3 SUMMIT trial in Q4/22, which it believes will support submission of an NDA with the U.S. FDA in Q1/23.
Updates on These Three Mining Stocks (09/19/2022)
Expert Clive Maund takes a look at charts from Infinitum Copper Corp., Reyna Gold Corp., and Reyna Silver Corp. to tell you where he thinks these three mining stocks are going.
Mining Co. Reports More Good Drill Results in Spain (09/19/2022)
"It certainly appears that Romanera could prove to be a significant precious metals deposit," noted a Research Capital Corp. report.
Top-10 Producer Offers $150M for Nevada Gold Property (09/19/2022)
Coeur Mining Inc. shares traded 18% higher after the company reported it has agreed to sell its Southern Nevada Holdings to AngloGold Ashanti Ltd. for $150 million in cash. The purchase by AngloGold includes provisions for an additional payment of $50 million if the project is shown to host a total resource of 3.5 million ounces of gold or higher.
Second Trial of New Eczema Drug To Commence in Q4/22 (09/17/2022)
The purpose behind this complementary study is to potentially expand the treatment's target patient population, noted an H.C. Wainwright & Co. report.
Silver Explorer Expands Golden Triangle Drilling Campaign (09/16/2022)
Dolly Varden Silver Corp. is adding a fourth diamond drilling rig to its campaign at its Kitsault Valley project in British Columbia after seeing big returns.
Tech Co. Ready To Advance in a New Bull Market (09/16/2022)
Expert Clive Maund reviews Danavation Technologies Corp. after the completion of a large base pattern to see whether he believes it is a Buy.
Junior Closes on Deal for Critical Metals, Minerals Project (09/16/2022)
Copper and other critical metals and minerals are the backbone of the world's switch to green energy, and Rover Metals Corp. hopes to supply some of them.
FDA Grants Approval for Drug Improving Kidney Function (09/16/2022)
Shares of Mallinckrodt Plc. traded 28% higher yesterday after the company reported that the U.S. FDA has issued approval for its Terlivaz® (terlipressin) for injection for use in treating hepatorenal syndrome, a serious and life-threatening condition that is accompanied by rapid reduction in kidney function.
Bowling Center's Shares Score New 52-Week High (09/16/2022)
Shares of bowling center operator Bowlero Corp. traded 7.5% higher and rolled to a new 52-week high after the company reported Q4/22 and FY/22 financial results that included a 130.7% YoY increase in annual revenue.
Price Target on US Biopharma Co. Boosted by $15 (09/15/2022)
The increase came after positive clinical trial results on one of its lead drug candidates differentiating it from a competitor, noted a BTIG report.
New Drug Shown To Help Patients With Desmoid Tumors (09/15/2022)
This oral gamma-secretase inhibitor met the primary and secondary endpoints in a Phase 3 clinical trial, noted a Wedbush report.
Three-Part Approach to Advancing Gold Project Gets Results (09/15/2022)
The explorer recently hit upon the main deposit's feeder zone, discovered a new vein nearby and keeps drilling high-grade gold intercepts, noted a ROTH Capital Partners report.
Publishing Co. Rated an 'Interesting Speculative Play' (09/15/2022)
After a relatively big buyer appeared a week ago and bought a lot of stock from Legible Inc., expert Clive Maund believes something may be on the horizon for the publishing company.
NDA for Dry Eye Disease Drug on Track for Q4/22 Submission (09/15/2022)
This and the biopharma's other treatment candidates for ocular diseases are underappreciated, which translates to an investment opportunity, noted an Oppenheimer report.
Several Trials of Co.'s Fluid Pump To Read Out This Year (09/14/2022)
Positive topline data could boost the share price of this Swiss medical device firm, noted an H.C. Wainwright & Co. report.
Analyst Says Mining Junior Well Positioned To Ride Out Gold Bear Market (09/14/2022)
The company has numerous elements working in its favor, including a fully permitted gold project only 12 months away from initial production, noted an Eight Capital report.
Copper Junior Sees 'Beautiful' Drilling Results in Mexico (09/14/2022)
Infinitum Copper Corp. hopes to help close a coming copper shortage with the red metal coming out of its La Adelita project in Mexico.
Oil & Gas Producer Sees 145% Rise in FY22 Production (09/14/2022)
Shares of Evolution Petroleum Corp. traded 19% higher after the U.S. onshore oil and gas producer reported that during FY/22 it increased production by 145% YoY and achieved a 233% increase in annual revenue. The company advised that it is raising its quarterly cash dividend by 20% and is initiating a $25 million share buyback program.
Co. Advancing Drug Class With Broad Potential (09/13/2022)
This developer of C1q-targeting therapeutics, with a catalyst-rich 18 months ahead, warrants analyst coverage, noted a BTIG report.
Rare Earths Co. Reaches Important Milestone Before PFS (09/13/2022)
The explorer agreed to work together with a local First Nations community as it advances its critical elements project in British Columbia, noted a Noble Capital Markets report.
Biotech Co.'s Target Six Times Current Price (09/13/2022)
One Phase 2 clinical trial showing LSD reduced symptoms of anxiety bodes well for other studies of LSD in this indication. In light of this, Oppenheimer & Co. gave this biotech company a target price that is over six times its current share price.
Expert Says Life Science Co.'s Technical Setup Is 'Exceptionally Positive and Keeps Getting Better' (09/13/2022)
Expert Clive Maund reviews the 6-month and 15-month charts for Awakn Life Sciences Corp. to explain why he thinks this company's technical setup is exceptionally positive.
Hycroft Reports High Gold and Silver Grades at Nevada Mine (09/13/2022)
Shares of Hycroft Mining Holding Corp. traded 12% higher after the Nevada gold and silver mining firm reported initial drill results from its Hycroft Mine. The company commented that it has encountered multiple zones of continuous higher-grade silver that extend further than prior interpretations.
Healthcare Co.'s To Develop Fast-Dissolving MDMA Tablet (09/12/2022)
One biopharma co. is teaming with a much larger pharmaceutical company to develop a fast-dissolving oral tablet to deliver MDMA to patients with Alcohol Use Disorder. Find out why developing an oral tablet could benefit the company in the long run.
Analyst Says Biopharma's New Inhaled Antifungal Drug Shows Promise (09/12/2022)
Trial results are expected later this month, but anecdotal data available now suggest the findings should be positive, noted a ROTH Capital Partners report.
Explorer Posts More Good Drill Results at Iberian Belt Property (09/12/2022)
Emerita Resources Corp. reported drill results from five new holes at its Iberian Belt West Project in Spain. Research Capital Corp. commented in a research note that Emerita is proceeding with its aggressive 2022 drill program and expects to resume around-the-clock drilling within the next two weeks. The research firm stated it is maintaining its Speculative Buy rating on the company.
Rare Earths Explorer Enters Agreement With Native Group (09/12/2022)
Defense Metals Corp., which hopes to compete with China in the production of vital rare earth elements, has entered into an agreement with the McLeod Lake Indian Band in British Columbia.
Financial Firm Covers Mining Co. With Assets in US (09/12/2022)
This "uniquely positioned" junior explorer has a large land package in a prolific, historical South Dakota mining district and top-tier management and board members, Canaccord Genuity noted.
Powell Says Money Not Important for Inflation (09/12/2022)
Expert Adrian Day looks at recent comments from central bankers and comments on the little news this week from Osisko Gold Royalties Ltd.
Red Lake Miner Posts Record Monthly Gold Production (09/12/2022)
Pure Gold Mining Inc. shares traded 30% higher after the company reported that during August 2022, it produced 4,595 ounces of gold at its Red Lake Greenstone Belt property. The firm additionally reaffirmed its Q3/22 estimates calling for production of 8,700-12,300 ounces of gold.
Three Metal Stocks To Buy This Morning (09/10/2022)
Expert Clive Maund reviews three metal stocks he believes are worth your while.
European Explorer Hits Big Silver Intercept in Bosnia (09/09/2022)
One silver explorer in Bosnia and Herzegovina hopes its first drill result is a sign of things to come as it continues to drill test its 90%-owned silver-lead-zinc project.
Expert Rates Silver Co. a Strong Speculative Buy (09/09/2022)
Expert Clive Maund reviews the latest updates in Silver X Mining Corp.'s stock to tell you where he believes the company is headed.
Cloud Security Co.'s FY22 Revenue Rises 62% (09/09/2022)
Shares of Zscaler Inc. traded 22% higher after the cloud-security platform provider reported Q4/22 financial results that included a 61% YoY increase in total revenue. The company's Zero Trust Exchange platform utilizes what the firm claims is "the largest security cloud on the planet" to make doing business easier, faster, and more productive.
US Co. To Regain All Rights to Its AGHD Diagnostic Test (09/08/2022)
This is set to happen because the biopharma's commercialization partner recently terminated its agreement over the product, noted an H.C. Wainwright & Co. report.
Expert Says It's a 'Good Time to Buy' Gold Corp.'s Stock (09/08/2022)
Expert Clive Maund reviews the 6-month chart for Dakota Gold Corp. in light of its retreat in recent weeks.
Medtech Co. Meets Primary Endpoints in Ph. 3 Glaucoma Trials (09/08/2022)
Glaukos Corp.'s shares traded 18% higher yesterday after the company reported that in two separate Phase 3 trials, its iDose TR met its primary efficacy endpoints by lowering intraocular pressure in glaucoma patients.
Why Did This Gold Stock Jump 31% In One Day? (09/08/2022)
Read the article below to find out what led to the jump in Reyna Gold Corp.'s stock.
Green Tech Co.'s Permit Would Benefit Farmers, Investors (09/08/2022)
BacTech Environmental Corp. realized much of the land for its Ecuador bioleaching plant isn't needed yet, so it is letting local workers continue to farm thousands of cocoa trees.
Outlook for Chile After the Weekend Rejection of the New Constitution (09/08/2022)
In light of this weekend's rejection of a new constitution by the Chilean government, expert Clive Maund shares his view on how he believes this will impact companies within the region.
Nevada Gold Play Finds Undrilled Vein in Idaho (09/08/2022)
The discovery of a gold vein can dramatically change the outlook for a gold project. So when an un-drilled gold vein is discovered outcropping at surface at a gold project with a defined resource, it certainly warrants further investigation.
Biopharma Co. Receives Approval From FDA Panel for ALS Drug (09/08/2022)
Amylyx Pharmaceuticals Inc.'s shares traded 51% higher after the company reported that a U.S. FDA advisory committee has voted to support approval of the firm's AMX0035 for use in treating amyotrophic lateral sclerosis. Although the committee's recommendation is not binding, it is expected that the decision will provide staunch support for approval of the firm's pending NDA for AMX0035, which has a target action date of September 29, 2022.
Biopharma Co. Transforming Injected Drugs Into Pills (09/07/2022)
This Israeli firm recently attracted the attention of the US-based financial institution, H.C. Wainwright & Co., which launched analyst coverage of it.
Expert Says Life Science Corp.'s Technical Case Is Becoming Compelling (09/07/2022)
Expert Clive Maund shares his view on Awakn Life Sciences Corp. as its stock continues to strengthen.
Gold Co. Works To Attract Large-Tier Partner (09/07/2022)
One analyst says the work Seabridge Gold Inc. is putting in to get a permanent environmental certification could help it attract a large-tier partner in British Columbia’s Golden Triangle.
Why This Expert Believes Silver Investments Are at or Close to a Major Bottom (09/07/2022)
With the latest drop in the silver market, expert Clive Maund reviews his opinion on where he thinks silver stocks are going and why investors should play close attention to this precious metal.
How Long Will the Fed Keep Going? (09/07/2022)
Expert Adrian Day takes a look at Federal Reserve policy after Jackson Hole and what it might mean for the markets, plus updates developments at some companies on his list.
Oil & Gas Spinout Co Is a 'Good Buying Opportunity,' Analyst Says (09/07/2022)
This firm is undervalued, has a near-producing oil asset in Alberta with large resource potential and upside, and is pursuing an opportunity to expand in Thailand, noted Research Capital Corp., which initiated coverage on it.
Two Talks On New Cancer Drug Slated for Meeting This Week (09/06/2022)
The upcoming discussions pertain to a biopharma's clinical stage T-cell therapy as a treatment for solid tumors, noted a ROTH Capital Partners report.
Leading Producer to Advance Six Japan Gold Projects (09/06/2022)
Japan Gold Corp. shares traded 18% higher after the company reported its development partner and industry major Barrick Gold Corp. has chosen six of its gold projects in Japan to be moved forward to the second evaluation phase for advancement.
Drilling Fills Gaps Between Resource Pits at Gold Project (09/04/2022)
New results from this area between two deposits show greater widths and consistent grades when compared to previously reported intercepts from there, noted a National Bank of Canada report.
Will Pharma Co. Keep Pushing Higher After Full Data Set Released on Lung Disease Study? (09/04/2022)
One small-cap pharma co. just published more good news on a possible treatment for patients suffering from idiopathic pulmonary fibrosis, a lung disease that's usually terminal. Find out why the company has more near-term catalysts and may continue to build on an 84% gain since a private placement in mid-August.
Mining Co. Proves Two Gold Zones Connected (09/03/2022)
New drill results from this Idaho project also showed there is at-surface mineralization of higher grades than the average of the current resource, noted a Desjardins report.
Results Point to Bulk Mining Potential at Idaho Gold Project (09/02/2022)
Drill results from Liberty Gold Corp.’s flagship Black Pine project in Idaho show that the site’s largest areas of concentrated gold are connected.
Denmark Co. To Buy US Biopharma Co. for $1.1 Billion (09/02/2022)
Forma Therapeutics Holdings Inc. shares traded 51% higher yesterday after the company reported it agreed to be acquired by Denmark's Novo Nordisk A/S in an all-cash deal for $20.00 per share. With the acquisition, Novo Nordisk aims to expand its global presence in the treatment of rare blood disorders and sickle cell disease.
B.C. Mining Explorer To Start Trading on CSE Sept. 6 (09/02/2022)
The company is in the process of meeting its obligations to earn 100% of a Vancouver Island property that is prospective for precious and base minerals . . . and sasquatches.
Oil & Gas Producer Benefits from Surge in Natural Gas Prices (09/02/2022)
Shares of Trillion Energy International Inc. traded 14% higher to a new 52-week high after the company reported it has increased the price it receives for natural gas by 47% to US$31/Mcf.
'No End in Sight' Yet of Gold System at Idaho Asset (09/01/2022)
New drill results highlight intra-pit continuity of mineralization and resource expansion potential, noted a Haywood Securities report.
Expert Rates Pharma Co. An Immediate Buy (09/01/2022)
Expert Chris Temple gives his view on Algernon Pharmaceuticals stock in light of its positive results for its Phase 2a study for the treatment of idiopathic pulmonary fibrosis and chronic cough.
More Archives
2024Oct Sep Aug Jul Jun May Apr Mar Feb Jan
2023Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2022Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2021Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
